An improved non-toxic soft tissue filler is provided. The soft non-toxic tissue filler consists of textured surfaced spherically shaped solid particles of a size range of between about 32 and 90 microns (depending on the concentration that is desired) that are suspended evenly in a gel as a carrier. The solid particles are preferably a non-ceramic cured polymer such as polymethylmethacrylate (PMMA). The gel is a combination of a cellulose polysaccharide such as carboxymethylcellulose (CMC) and an alcohol such as polyvinyl alcohol (PVA) dissolved in water or some other solvent. The filler is used by injection in order to augment a patient's soft tissue as well as to correct soft tissue defects.